Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin (RelapC)
This study has been terminated.
(Recruitment problems in Denmark and Norway)
Sponsor:
Göteborg University
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Göteborg University
ClinicalTrials.gov Identifier:
NCT00641654
First received: March 17, 2008
Last updated: August 29, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |